Antitumor Activity of the New Bcl-2/Bcl-xl Inhibitor S44563 in Primary Human Uveal Melanoma Xenografts

被引：0
|
作者：
Decaudin, D. [1 ]
Nemati, F. [1 ]
De Montrion, C. [2 ]
Lang, G. [1 ]
Sastre, X. [3 ]
Berthier, L. Kraus [2 ]
Dahmani, A. [1 ]
Desjardins, L. [4 ]
Piperno-Neumann, S. [5 ]
Depil, S. [2 ]
机构：
[1] Inst Curie, Lab Preclin Invest, Paris 05, France
[2] Servier Labs, Suresnes, France
[3] Inst Curie, Dpt Tumor Biol, Paris 05, France
[4] Inst Curie, Dpt Ophthalmol, Paris 05, France
[5] Inst Curie, Dpt Med Oncol, Paris 05, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
777
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [21] Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis
    Hong, Z
    Rosdahl, I
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (03) : 661 - 666
  • [22] Structure-Based Design of Potent Bcl-2/Bcl-xL Inhibitors with Strong in Vivo Antitumor Activity
    Zhou, Haibin
    Aguilar, Angelo
    Chen, Jianfang
    Bai, Longchuan
    Liu, Liu
    Meagher, Jennifer L.
    Yang, Chao-Yie
    McEachern, Donna
    Cong, Xin
    Stuckey, Jeanne A.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6149 - 6161
  • [23] Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL
    Mekori, YA
    Gilfillan, AM
    Akin, C
    Hartmann, K
    Metcalfe, DD
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) : 171 - 174
  • [24] Human Mast Cell Apoptosis Is Regulated Through Bcl-2 and Bcl-XL
    Yoseph A. Mekori
    Alasdair M. Gilfillan
    Cem Akin
    Karin Hartmann
    Dean D. Metcalfe
    Journal of Clinical Immunology, 2001, 21 : 171 - 174
  • [25] The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
    Heisey, Daniel A. R.
    Lochmann, Timothy L.
    Floros, Konstantinos V.
    Coon, Colin M.
    Powell, Krista M.
    Jacob, Sheeba
    Calbert, Marissa L.
    Ghotra, Maninderjit S.
    Stein, Giovanna T.
    Maves, Yuki Kato
    Smith, Steven C.
    Benes, Cyril H.
    Leverson, Joel D.
    Souers, Andrew J.
    Boikos, Sosipatros A.
    Faber, Anthony C.
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1664 - 1675
  • [26] Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: A molecular dynamics simulation approach
    Wakui, Naoki
    Yoshino, Ryunosuke
    Yasuo, Nobuaki
    Ohue, Masahito
    Sekijima, Masakazu
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 79 : 166 - 174
  • [27] Expression Of Bcl-2, Bax and Bcl-xl in Human Gliomas: A Re-appraisal
    Stéphane Martin
    Claire Toquet
    Lisa Oliver
    Pierre-François Cartron
    Pascale Perrin
    Khaled Meflah
    Paulette Cuillère
    François M. Vallette
    Journal of Neuro-Oncology, 2001, 52 : 129 - 139
  • [28] Expression of bcl-2, bax and bcl-xl in human gliomas:: A re-appraisal
    Martin, S
    Toquet, C
    Oliver, L
    Cartron, PF
    Perrin, P
    Meflah, K
    Cuillère, P
    Vallette, FM
    JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (02) : 129 - 139
  • [29] Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo
    Lin, Jie
    Wu, Yongji
    Yang, Dajun
    Zhao, Yongqiang
    ONCOLOGY REPORTS, 2013, 30 (02) : 731 - 738
  • [30] BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
    Erinna F. Lee
    Tiffany J. Harris
    Sharon Tran
    Marco Evangelista
    Surein Arulananda
    Thomas John
    Celeste Ramnac
    Chloe Hobbs
    Haoran Zhu
    Gency Gunasingh
    David Segal
    Andreas Behren
    Jonathan Cebon
    Alexander Dobrovic
    John M. Mariadason
    Andreas Strasser
    Leona Rohrbeck
    Nikolas K. Haass
    Marco J. Herold
    W. Douglas Fairlie
    Cell Death & Disease, 10
12345